Knowledge and attitude towards cervical cancer and screening practices among women of reproductive age in Nandi County, Kenya
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20261750Keywords:
Attitude, Cervical cancer, Cervical cancer screening, KnowledgeAbstract
Background: Cervical cancer remains a major public health concern, especially in developing countries such as Kenya. Despite the availability of screening services, uptake among women remains low. This study assessed knowledge and attitudes towards cervical cancer and their influence on screening practices among women of reproductive age in Nandi County, Kenya.
Methods: A descriptive correlational design was employed among 341 women aged 20-49 years attending maternal and reproductive health services at Kapsabet Referral Hospital. Data were collected using structured questionnaires and analyzed using SPSS version 23. Descriptive statistics and Pearson’s correlation analysis were used to examine relationships between knowledge, attitudes, and screening practices.
Results: Most respondents (83.8%) had heard about cervical cancer, although detailed knowledge of symptoms, risk factors, and screening methods was moderate. Positive attitudes towards screening were reported by the majority of participants, with 79.4% agreeing that screening is beneficial. However, screening uptake remained low. Pearson’s correlation analysis showed significant positive relationships between knowledge and screening uptake (r=0.38, p<0.05) and between attitudes and screening practices (r=0.41, p<0.05).
Conclusions: Although respondents demonstrated moderate knowledge and positive attitudes towards cervical cancer screening, actual screening uptake remained low. Addressing socio-cultural barriers, misconceptions, and limited access to screening services is essential to improve cervical cancer screening practices among women in rural Kenya.
References
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203.
Bruni L, Albero G, Serrano B, Roura E, Alemany L, Cowan M, et al. Global estimates of cervical cancer screening coverage. Lancet Glob Health. 2022;10(2):e1115–27.
Ministry of Health Kenya. National Cancer Control Strategy 2022–2027. Nairobi: Government Press; 2022.
Ng’ang’a A. Cervical cancer burden in Kenya. Afr J Health Sci. 2018;31(2):1–10.
Aduda D, Kibachio J, Wachira J, Ngugi C. Factors influencing cervical cancer screening uptake in Kenya. BMC Public Health. 2020;20:1–10.
Kinyua E. Factors associated with cervical cancer screening uptake in Kenya. BMC Public Health. 2019;19:1–9.
Singh S. Cervical cancer screening disparities in Africa. Int J Cancer. 2023;152(4):789–98.
Basu P, Mittal S, Banerjee D, Singh P. Knowledge and awareness of cervical cancer. Indian J Cancer. 2019;56(1):45–50.
Heena H, Durrani S, AlFayyad I, Riaz M, Tabasim R, Parvez G, Abu-Shaheen A. Knowledge, Attitudes, and Practices towards Cervical Cancer and Screening amongst Female Healthcare Professionals: A Cross-Sectional Study. J Oncol. 2019;2019:5423130.
Chisale Mabotja M, Levin J, Kawonga M. Beliefs and perceptions regarding cervical cancer and screening associated with Pap smear uptake in Johannesburg: A cross-sectional study. PLoS One. 2021;16(2):e0246574.
Mafiana JJ, Dhital S, Halabia M, Wang X. Barriers to uptake of cervical cancer screening among women in Nigeria: a systematic review. Afr Health Sci. 2022;22(2):295.
Mingo AM. Cervical cancer screening in Africa: A systematic review. BMC Cancer. 2020;20:1–12.
Petersen I. Structural barriers to screening services. Health Policy Plan. 2022;37(3):345–56.
Ruddies F. Determinants of screening uptake. Cancer Epidemiol. 2020;65:101696.
Tsegay G. Attitudes towards screening in Ethiopia. PLoS One. 2021;16(4):e0249902.
World Health Organization. Cervical cancer prevention guidelines. Geneva: WHO; 2021. Available at: https://www.who.int/publications/i/item/9789240040434. Accessed on 3 March 2026.
Zhang L. HPV and cervical cancer risk factors. Cancer Res. 2022;82(5):1023–30.